Growth Metrics

Qiagen (QGEN) EBIAT (2016 - 2026)

Qiagen's EBIAT history spans 18 years, with the latest figure at $68.0 million for Q1 2026.

  • On a quarterly basis, EBIAT fell 25.03% to $68.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $402.2 million, a 12.69% decrease, with the full-year FY2025 number at $424.9 million, up 408.28% from a year prior.
  • EBIAT hit $68.0 million in Q1 2026 for Qiagen, down from $107.8 million in the prior quarter.
  • Over the last five years, EBIAT for QGEN hit a ceiling of $183.5 million in Q2 2024 and a floor of $68.0 million in Q1 2026.
  • Historically, EBIAT has averaged $100.5 million across 5 years, with a median of $90.8 million in 2025.
  • Biggest five-year swings in EBIAT: soared 127.09% in 2024 and later crashed 47.54% in 2025.
  • Tracing QGEN's EBIAT over 5 years: stood at $88.8 million in 2022, then increased by 9.93% to $97.7 million in 2023, then fell by 9.57% to $88.3 million in 2024, then grew by 22.09% to $107.8 million in 2025, then tumbled by 36.9% to $68.0 million in 2026.
  • Business Quant data shows EBIAT for QGEN at $68.0 million in Q1 2026, $107.8 million in Q4 2025, and $130.0 million in Q3 2025.